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Background: Diagnosis of the metabolic syndrome (MS) is crucial for health care practitioners to identify at risk
people for early treatment. Visceral obesity may make unnecessary other laborious measures of insulin resistance.
The aim of this study was to see whether waist circumference (WC) can predict insulin resistance as well as MS in a
group of Iranian elderly.
Methods: Out of 94 nondiabetic elderly, thirty three subjects were recognized with MS. MS diagnosis was based on
NCEP ATP III (National Cholesterol Education Program Adult Treatment Panel III) and IDF (International Diabetes
Federation) definitions. HOMA (Homeostasis Model Assessment) index was used to measure insulin sensitivity.
Insulin resistance (IR) was defined as top quartile of HOMA.
Results: In both sexes, WC and HOMA index were significantly positively correlated. The optimal waist
circumference (OWC) cutoff point was 94.5 cm for men and 90.5 cm for women. The high sensitivity (0.80) and
specificity (0.84) of WC in males indicates the proportion of IR which is correctly identified and recognizes all non-IR
males as such. In regression model only the TG level was associated with WC. But the WC is strongly associated
with HOMA-IR.
Conclusions: While OWC is very likely a good measure to exclude non-IR subjects in our study, determination of
optimal WC to identify elderly IR subjects warrants further study in a larger sample of the general population.
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The clustering of a group of heart disease risk factors, and
their association with insulin resistance, led investigators
to propose the existence of the condition “metabolic syn-
drome (MetS)” [1] or “insulin resistance” [2]. This health
condition is very prevalent in Iranian population [3] and
its frequency is higher among older Iranian people [3].
Diagnosis of the metabolic syndrome is crucial for health
care practitioners to identify at risk people for early treat-
ment, long-term management and cardiovascular disease
prevention. Based on a definition published by the Inter-
national Diabetes Federation (IDF) [4] and National Chol-
esterol Education Program Adult Treatment Panel III [5]
(NCEP-ATP III) [5], abdominal obesity is a key factor for* Correspondence: mramini@tums.ac.ir
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reproduction in any medium, provided the ordiagnosis of metabolic syndrome and it probably is the po-
tential link between metabolic syndrome and insulin re-
sistance [6]. On the other hand waist circumference (WC)
is an independent risk factor for cardiovascular disease [1].
Blood sampling is required for measurement of the other
components of metabolic syndrome. As well as WC is an
easy and clinically useful scale to identify metabolic syn-
drome. It has been suggested that in elderly men WC is a
better indicator of metabolic abnormalities than percent
body fat [7]. It is also a good measure of central adiposity
[8-10]. Intra-abdominal obesity or visceral fat is strongly
associated with metabolic disturbances and insulin resist-
ance [11,12]. Insulin sensitivity is traditionally determined
by euglycaemic-hyperinsulinaemic clamp technique [13],
but in general population; it is more convenient and cost-
effective to estimate homoeostasis model assessment
(HOMA index) using plasma glucose and insulin [14,15].al Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Some longitudinal studies recommended higher cut-point
for the elderly than the adult population [16]. While it has
been stated that WC< 100 excludes insulin resistance in
both sexes in adults, however in elderly women a WC
>88 cm has been shown to indicate a high likelihood of in-
sulin resistance and is almost as good as MetS defined
using the NCEP criteria in predicting Insulin Resistance
(IR) [17]. Due to ethnic-specific values for WC in IDF def-
inition as well as its determination in an Iranian popula-
tion [18], it is noteworthy to see whether waist
circumference would predict insulin resistance as good as
metabolic syndrome in the Iranian elderly people.
Methods
A cross-sectional study was conducted among elderly
residents of the Kahrizak Charity Foundation between
2007–2008 in Tehran, Iran. Subjects ≥ 60 years of age
were considered elderly. Data collection was performed
during annual health assessment of elderly subjects.
Among identified living residents of Kahrizak, volunteers
were recruited as prospective participants. Primary data
such as age, sex, cause of admission, code of each resi-
dent, residency duration and admission unit were
exploited from medical records and recorded in a spe-
cific questionnaire designed for the purpose of study.
Subjects and study criteria
Data for this study were from the baseline data of Kahrizak
Elderly cohort study; this was a longitudinal institutional-
ized based study for recognizing of risk factors of the mor-
bidity and mortality in older people which was conducted
in the Kahrizak Charity Foundation. Additional detail in-
formation about this study was explained elsewhere [19].
Those aged ≥ 60 who were not bedridden, considered
healthy, according to the Mini Mental State Examination
(MMSE) questionnaire (score >21) [20], and were non-
diabetic , had no end stage disease such as cancer, chronic
kidney disease or liver failure and volunteer to participate
included in the study.
Weight was measured in light clothing with bare feet to
the nearest 0.1 Kg using electronic scale and Height was
measured without shoes as the distance from the top of
the head to the bottom of the feet to the nearest 0.1 cm
using a stadiometer. Waist measurement was taken from
the midpoint between the iliac crest and the lower ribs
measured at the sides while standing. Blood pressure was
measured twice by a trained team according to The
Seventh Report of the Joint National Committee on
Prevention, Detection, Evaluation, and Treatment of High
Blood Pressure (JNC VII) criteria. Briefly, it was measured
with an automatic sphygmomanometer (Omron M7,
Japan) in the right arm in the sitting position after resting
for 5 minutes. Participants were recommended to avoidalcohol, cigarette smoking, caffeinated beverages, and ex-
ercise for at least 30 min before their blood pressure
measurement. An average of the two measurements was
recorded with 3 days interval during a week. Calibration
with a mercury sphygmomanometer had been done after
every 100 measurements (The Seventh Report of the Joint
National) [21]. Diabetes was defined according to the
American Diabetes Association [22].
The study protocol was approved by Endocrinology
and Metabolism Institute ethics committee and con-
formed to the Declaration of Helsinki. All subjects gave
written informed consent.
Biochemical analysis
Fasting venous samples were obtained. Blood samples
were centrifuged (10 min, RT, at 2000 RPM) in room
temperature. Serum aliquots were divided into micro
tubes and stored at −32°C until measurement. Fasting
blood sugar (FBS), Triglyceride (TG), Total Cholesterol
(TC), high density lipoprotein Cholesterol (HDL–C) was
measured by enzymatic method (Pars Azmun, Iran).
Plasma insulin was determined using ELISA method
(Denmark, Monobind, 2008).
Diagnosis
According to modified ATP (Adult Treatment Panel) III
criteria metabolic syndrome is identified by the presence
of at least three of the following components: increased
WC (>102 cm for men, > 88 cm for women), blood
pressure elevation (≥ 130/85 mmHg) and/or use of anti-
hypertensive medications, low HDL-C (<40 mg/dl in
men, < 50 mg/dl in women), high TG (≥ 150 mg/dl),
hyperglycemia (fasting glucose ≥ 100 mg/dl) and/or anti-
diabetic medications [5]. Metabolic syndrome based on
the IDF definition was defined as the ethnic definition
of WC for Iranian population (≥ 91.5 cm for men,
≥ 85.5 cm for women) [19] plus any of these two: blood
pressure elevation, reduced HDL cholesterol, raised TG
(with the same cut-offs as ATP III), or raised fasting
plasma glucose ( ≥ 100 mg/dl ).
HOMA index was calculated as described by Matthews
[fasting plasma glucose (mmol/L) × fasting insulin (μU/
ml)/22.5] [14].
According to European Group for the Study of Insulin
Resistance [23], IR was defined as top quartile of HOMA
in non-diabetic subjects.
Statistical analysis
Statistical analysis was performed using SPSS software,
15.0 (SPSS Inc Chicago). Values less than 0.05 were con-
sidered significant. Data were stratified by sex. Normality
of values was checked by Kolmogorov- Smirnov test. To
normalize skewed values, Log10 transformation was used
for Triglyceride and HOMA-IR. The association between
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dertaken using Pearson correlation. We used Receiver
Operating Characteristic (ROC) curve to determine the
cutoff point for WC in predicting IR. For determining the
accuracy of the ROC curve, Area under the ROC Curve
(AURC) was estimated for all components of metabolic
syndrome. To confirm the results of the ROC curve, linear
regression model was performed.
Results
One-hundred and forty five subjects ≥ 60 years partici-
pated in this study. Fifty one subjects were excluded be-
cause they had diabetes. 94 subjects (42 men and 52
women) were included in the study (Table 1). Then
HOMA-IR and TG no had normal distribution in the
Kolmogorov- Smirnov test. According to NCEP and IDF
criteria, the prevalence of metabolic syndrome in the
first 145 participants was 37.6% (23.2% male & 48.1% fe-
male) and 36.8% (26.8% male & 44.2% female), respect-
ively. After excluding diabetic ones, the prevalence of
metabolic syndrome based on the definition of NCEP
and IDF became 29.7% (13% male & 41.5% female) and
27% (13% male & 36% female), respectively.
The ROC curve analysis was conducted for the compo-
nents of metabolic syndrome on the criterion of HOMA-
IR which was categorized based on first quartile and three
other quartiles. The Figures 1 and 2 were demonstrated
this ROC curve analysis in male and female.
WC and HOMA index were significantly positively cor-
related in men (correlation coefficient: 0.590, P < 0.001)
and women (correlation coefficient: 0.246, P < 0.05). The
AURC TG was greater than that of the other components
of metabolic syndrome and the AURC WC ranked second.
In women the AURC FBS was greater than that of the
other components of metabolic syndrome and again the
AURC WC ranked second. AURC for WC was 0.83 (95%Table 1 General characteristic of participants
Variable Men (n = 42) Women (n = 52)
Mean ± SD Mean ± SD
Waist circumference (cm) 87.94 ± 11.48 89.91 ± 12.78
Body weight (kg) 62.18 ± 13.90 56.19 ± 13.86
Body mass index (kg/m2) 23.16 ± 4.42 25.31 ± 5.78
Triglycerides (mg/dl) 110.29 ± 56.25 152.17 ± 72.88
HDL-cholesterol (mg/dl) 43.18 ±13.01 46.53 ± 13.15
LDL-cholesterol (mg/dl) 106.56 ± 25.81 116.46 ± 30.41
Systolic blood pressure (mmHg) 136.91 ± 27.05 126.68 ± 23.57
Diastolic blood pressure (mmHg) 75.97 ±14.34 73.59 ± 13.67
Plasma glucose (mmol/L) 5.57 ± 0.67 5.41 ± 0.82
Serum insulin (mU/L) 4.76 ± 4.83 6.15 ± 5.19
HOMA index 1.21 ± 1.24 1.58 ± 1.64CI: 0.68-0.99) in men and 0.70 (95% CI: 0.56-0.85) in
women (Table 2).
The optimal cutoff point with the highest sensitivity
and specificity derived from the ROC curve in our study
was 94.5 cm for men and 90.5 cm for women. Sensitivity,
specificity, positive predictive value (PPV), negative pre-
dictive value (NPV), and proportion correctly classified
(PCC) for IR (Table 3). In men sensitivity, specificity and
NPV of OWC for IR was higher than those of NCEPWC
and IDFWC. However, in women’s sensitivity, specificity
and NPV of IDFWC for IR was greater than those of OWC
and NCEPWC. In the end PCC of IDFWC was greater than
PCC of NCEPWC and OWC.
In univariable and multivariable logistic regression,
there was only an association between WC and TG be-
tween the components of MetS. But there was a strong
association between WC and HOMA index (Table 4).
Discussion
In this study, we compared OWC and NCEP WC as well
as IDF WC in the prediction of IR with non-diabetic
Iranian elderly residents of the Kahrizak Charity Foun-
dation. We found OWC is a better predictor of IR after
TG in men and after FBS in women. In men NPV of
OWC was greater than NPV’s of IDF WC and NCEPWC.
This means that with a probability of 0.96 a man with
WC less than 94.5 will not have IR. In women, on the
other hand, we can claim that with a probability of 0.82
a female with WC less than 90.5 will not be affected by
IR. While OWC is very likely a good measure to exclude
non-IR subjects; IDFWC has a better predictive value for
IR than NCEPWC and OWC in this population of elderly
Iranians. In clinical practice because measurement of
WC is easier than TG, it is justified to investigate its ap-
plicability to predict IR. Although AURCTG in men and
AURCFBS in women were greater than AURCWC, how-
ever OWC was good (0.8) in men and fair (0.7) in
women at separating non-IR from IR subjects.
There is some pathophysiologic justification about
waist circumference and insulin resistance. The waist cir-
cumference is one of the most user index for abdominal
obesity and visceral fat accumulation. The studies have
been shown that accumulation of adipose tissue could in-
crease releasing of free fatty acids, inflammatory cyto-
kines and decrease secretion of adiponectin. These
changes in mediators could decrease insulin sensitivity in
muscle tissues and subsequently reduce insulin-mediated
glucose uptake [24].
Moreover, OWC as determined by the ROC curve indi-
cates the point with the highest sensitivity and specificity.
The high sensitivity of OWC (0.80) among the male elderly
indicates the proportion of IR which was correctly diag-
nosed and its high specificity (0.84) means the proportion
of correctly identified non-IR. Waist circumference is a
Figure 1 ROC curves of the components of metabolic syndrome on criterion of insulin resistance for men.
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defined by NCEP: ATP-III and IDF definition [4]. In
addition, metabolic syndrome and insulin resistance are
strongly associated with intra-abdominal obesity or vis-
ceral fat [11,12]. In 2005 German investigators performed
a nationwide screening of 35 869 unselected patients to
estimate their cardiovascular risk. At the end, they con-
cluded that routine measurement of WC in primary care
attendees is a suitable screening tool to identify those with
high cardiovascular risk in which a further diagnostic
work-up is justified [25]. Moreover, a recent population-
based study has shown the suitability of WC in identifying
cardiometabolic conditions and risk factors in primaryFigure 2 ROC curves of the components of metabolic syndrome on ccare facilities. They have investigated whether WC or BMI
were strong associates of CVD, diabetes mellitus, lipid dis-
orders and hypertension. The results of such studies have
shown WC as a strong associate of CVD and diabetes
mellitus even in those lean or overweight by BMI. The au-
thors attributed such effect to the abdominal fat accumu-
lation which contributes to the insulin resistance [26].
Another study in a large population shown that waist cir-
cumference could use as a single anthropometric pre-
dictor of all cause of mortality [27]. A study in Iran was
shown that the WC is better than the BMI and waist to
hip ratio could predict the metabolic syndrome [28].
Another study reported that the WC more related toriterion of insulin resistance for women.
Table 2 Area under the curve of MS components
according to sex
Measure Men Women
AURC Pvalue AURC Pvalue
Waist Circumference 0.83 0.01 0.70 0.04
FBS 0.76 0.02 0.85 0.01
TG 0.87 0.00 0.53 0.72
HDL 0.77 0.06 0.44 0.90
SBP 0.54 0.42 0.54 0.45
DBP 0.50 0.52 0.43 0.71
FBS; Fasting Blood Sugar, TG; Triglyceride, HDL; High Density Lipoprotein,
SBP; Systolic Blood Pressure, DBP; Diastolic Blood Pressure.
Table 4 Association between the components of
metabolic syndrome and insulin resistance with OWC in
univariate and multivariable logistic regression models
Variables Univariate analysis Multivariable analysis*
OR (CI 95% OR) OR (CI 95% OR)
High blood
pressure
0.41 (0.17 – 1.02) 0.41 (0.17 – 1.02)
High blood
triglyceride levels
2.86 (1.115 – 7.08) 2.88 (1.16 – 7.15)
Low blood
HDL-C levels
2.09 (0.83 – 5.26) 2.10 (0.83 – 5.28)
High blood
glucose levels
2.42 (0.46 – 12.80) 2.69 (0.49 – 14.73)
High HOMA-IR
index
6.00 (1.62 – 22.18) 6.12 (1.64 – 22.80)
Notice: The cut-points for construction of WC dummy variable were 90.5 cm
for women and 94.5 for men.
*Adjusted for age.
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years than those aged < 50 years [29]. A study reported
that the optimal BMI and WC should redefine in older
people and may be the cut-point for the categorizing of
these anthropometric measures about this age group
should consider larger than the adult population [16].
On the other hand the correlation of abdominal obes-
ity with insulin resistance is to the extent that more la-
borious measures of insulin resistance seem unnecessary
[30]. In the elderly (67–78 y) WC and abdominal sagittal
diameter are reported to be more closely correlated with
to metabolic risk factors [31].
The WC cutoff point has been determined for the
diagnosis of metabolic syndrome in Iranian adult popu-
lation [19]. In this study, we assessed the suitability of
WC in predicting IR in elderly Iranians. While the
current study has been shown the suitability of OWC in
identifying IR elderly men, Nilsson et al. [18] reported
waist circumference as a useful tool in predicting IR in
Swedish elderly women (WC >88 indicated a high likeli-
hood of IR). Discrepancies between our results and
Nilsson et al. [18] may be due to difference in identifying
MS subjects using IDF criteria. We used definition
of WC for Iranian population (≥ 91.5 cm for men,
≥ 85.5 cm for women) whereas Nilsson et al. [18] used
different cut-offs (WC ≥ 94 cm for men, ≥ 80 cm for
women). Another explanation may be the size of waist
circumference. Median of waist circumference in malesTable 3 Predictive value of insulin resistance using
optimal waist circumference, NCEP and IDF definition of
MS
Measure Men Women
NCEP IDF WC NCEP IDF WC
Sensitivity 0.75 0.77 0.80 0.48 0.59 0.50
Specificity 0.79 0.83 0.84 0.57 0.63 0.52
Positive predictive value 0.33 0.6 0.4 0.40 0.23 0.18
Negative predictive value 0.91 0.94 0.96 0.55 0.85 0.82
Proportion correctly classified 0.83 0.9 0.83 0.52 0.61 0.51was greater than that of women in the Swedish study
[18]. On the contrary, in our study men and women did
not differ in terms of waist circumference. This discrep-
ancy could be attributed to the difference in body com-
position and distribution of fat. Epidemiological studies
have shown the difference in the distribution of fat be-
tween South Asians and Whites (Caucasians) [30-32].
In the current study, OWC had the ability to discrim-
inate among IR and non-IR males. Parity and meno-
pause may justify this difference. Findings from the
Third National Health and Nutrition Examination
Survey (NHANES) III demonstrated that increasing
parity was associated with increased WC [33]. Also,
CARDIA (Coronary Artery Risk Development In Young
Adults) study endorsed NHANES findings [34]. Estrogenic
attenuation during menopause contributes to the fat mass
augmentation and altered distribution of fat; especially in
the abdomen [35-38]. Sowers et al. [39] have reported WC
and body fat increase during the menopausal transition
[40]. There is controversy whether intra-abdominal fat ac-
cumulation is related to the process of ageing or meno-
pause [39,41-44]. Stevens et al. have concluded that
studies with an accurate method of body composition
measurement ascribed this alteration to menopause rather
than age [45].
The results of this study provide a very simple screen-
ing method for assessment of insulin resistance in older
people especially older men and for the aged people who
are at higher risk, more evaluation is carried out.
Some limitations of this study deserve comment. Due
to the cross sectional nature of this study, we were un-
able to estimate relative risk of being IR for those above
and below the optimal WC cutoff. In addition, the lim-
ited number of participants makes generalization of our
findings difficult in clinical practice in the elderly.
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of the participants. The physical activity could confound
the reported relationship. However the data of health
monitoring of KCF did not show a difference between
all the residents in term of the physical activity.
Conclusion
The fasting blood sugar measure is required to identify
IR in elderly Iranian women. In elderly Iranian men,
WC seems to perform as well as IDF criteria at predict-
ing IR. Also measured TG may be useful for diagnosis of
metabolic syndrome among older Iranian men. We sug-
gest further studies be carried out with larger samples of
elderly subjects to determine optimal WC cutoff in eld-
erly IR subjects.
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